Extended surgical interventions in children with retinoblastoma invasion into the optic nerve
https://doi.org/10.21682/2311-1267-2021-8-2-50-60
Abstract
Introduction. Standard eye enucleation (EE) may not always guarantee a sufficient length of resection of the optic nerve (ON) so that the tumor cells do not spread along the optic nerve at the intersection line. Surgical access and the scope of surgical intervention are determined by the spread and localization of the tumor, as well as the qualification of the operating team.
Purpose — to evaluate the role of extended surgical interventions in the spread of extraocular tumors on the ON.
Materials and methods. The study included 9 patients with retinoblastoma (RB) and macroinvasion of the ON during primary magnetic resonance imaging (MRI) and/or micromorphological invasion of the ON resection line after EE. 4 of the 9 patients were treated with primary/secondary EE, induction chemotherapy (CT) and high-dose CT (HDCT), radiation therapy (RT). 5 out of 9 patients underwent secondary extended surgical interventions: exenteration of the orbit (n = 1), osteoplastic lateral orbitotomy with precanal resection of the ON (n = 2) in combination with EE in one case, subfrontal craniotomy (n = 1) and orbitozygomatic craniotomy (n = 1) with prechiasmal resection of the ON and EE with adjuvant RT (excluding the latter case) and CT, without HDCT.
Results. It should be noted that the overall survival (OS) of 5 patients with complete microscopic resection (R0) after extended secondary operations was 75 ± 0.217 % with an average follow-up period of 77.25 ± 18.8 months, while in 4 patients with R1 (n = 4) without secondary extended operations with HDCT reached only 50 ± 0.25 % with an average follow-up period of 57 ± 24.8 months.
Conclusion. MRI is mandatory for the primary diagnosis of RB, especially when there is a risk of the tumor spreading through the ON. Secondary surgery with R0-resection has a positive effect on survival. The need for adjuvant RT and CT after surgery should be discussed.
About the Authors
T. L. UshakovaRussian Federation
Dr. of Sci. (Med.), Leading Researcher Surgical Department No. 1 of the Research Institute of Pediatric Oncology and Hematology at N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia, Professor at the Department of Pediatric Oncology named after Academician L.A. Durnov at Russian Medical Academy of Continuing Professional Education, Ministry of Health of Russia.
23 Kashirskoe Shosse, Moscow, 115478; Bld. 1, 2/1 Barrikadnaya St., Moscow, 125993.
SPIN-code: 2065-8779
E. A. Tuzova
Russian Federation
Student of the General Medicine Faculty at N.I. Pirogov Russian National Research Medical University, Ministry of Health of Russia.
1 Ostrovityanova St., Moscow, 117997.
A. D. Shutova
Russian Federation
Student of the General Medicine Faculty at N.I. Pirogov Russian National Research Medical University, Ministry of Health of Russia.
1 Ostrovityanova St., Moscow, 117997.
O. V. Gorovtsova
Russian Federation
Ophthalmologist Surgical Department No. 1 of the Research Institute of Pediatric Oncology and Hematology at N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia.
23 Kashirskoe Shosse, Moscow, 115478.
SPIN-code: 1606-1039
T. G. Gasparyan
Russian Federation
Cand. of Sci. (Med.), Neurosurgeon Neurosurgical (Oncological) Department of Research Institute of Clinical Oncology at N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia, Researcher of the Neurosurgical Department at Scientific Center of Neurology of the Ministry of Education and Science of the Russia.
23 Kashirskoe Shosse, Moscow, 115478; 80 Volokolamskoe Shosse, Moscow, 125367.
SPIN-code: 5198-5167
A. Kh. Bekyashev
Russian Federation
Dr of Sci. (Med.), Head of the Neurosurgical (Oncological) Department of Research Institute of Clinical Oncology at N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia.
23 Kashirskoe Shosse, Moscow, 115478.
V. G. Polyakov
Russian Federation
Academician of RAS, Dr. of Sci. (Med.), Professor, Head of Surgery Department No. 1, Advisor to the Director of the Research Institute of Pediatric Oncology and Hematology of N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia, Head of the Pediatric Oncology Department named after Academician L.A. Durnov at Russian Medical Academy of Postgraduate Education, Ministry of Health of Russia, Professor of the Department of Otorhinolaryngology Faculty of Pediatrics at N.I. Pirogov Russian National Research Medical University, Ministry of Health of Russia.
23 Kashirskoe Shosse, Moscow, 115478; Bld. 1, 2/1 Barrikadnaya St., Moscow, 125993; 1 Ostrovityanova St., Moscow, 117997.
SPIN-code: 8606-3120
References
1. Schlueter S., Metz K., Bornfeld N., Goricke S., Schlamann M., Sirin S., Biewald E. Intraokulare Raumforderungen im Kindesalter ohne Retinoblastom [Intraocular Tumors other than Retinoblastoma in Children]. Klin Monbl Augenheilkd. 2015;232(7):838-44. doi: 10.1055/s-0041-102899.
2. Magramm I., Abramson D.H., Ellsworth R.M. Optic nerve involvement in retinoblastoma. Ophthalmology 1989;96(2):217-22. doi: 10.1016/s0161-6420(89)32910-1.
3. Messmer E.P., Heinrich T., Hopping W., de Sutter E., Havers W., Sauerwein W. Risk factors for metastases in patients with retinoblastoma. Ophthalmology 1991;98(2):136-41. doi: 10.1016/s0161-6420(91)32325-x.
4. Rootman J., Hofbauer J., Ellsworth R.M., Kitchen D. Invasion of the optic nerve by retinoblastoma: a clinicopathological study. Can J Ophthalmol 1976;11(2):106-14. PMID: 1078326.
5. Shiels C.L., Shields J.A., Baez K., Cater J.R., De Potter P. Optic nerve invasion of retinoblastoma. Metastatic potential and clinical risk factors. Cancer 1994;73(3):692-8. doi: 10.1002/1097-0142(19940201)73:3<692::aid-cncr2820730331>3.0.co;2-8.
6. Ushakova T.L., Pavlovskaya A.I., Polyakov V.G. Morphological prognostic factors in children with unilateral retinoblastoma after initial enucleation. Oncokhirurgia = Oncosurgery 2011;3(4):4-8. (In Russ.).
7. Kozlova V.M., Kazubskaya T.P., Sokolova I.N., Alekseeva E.A., Babenko O.V., Bliznetz E.A., Ushakova T.L., Mikhaylova S.N., Lubchenko L.N., Polyakov V.G. Retinoblastoma: Diagnostics and Genetic Counseling. Onkopediatriya = Oncopediatria 2015;2(1):30-8. (In Russ.).
8. Lohmann D.R., Gallie B.L. Retinoblastoma. Adam M.P., Ardinger H.H., Pagon R.A., Wallace S.E., Bean L.J.H., Stephens K., Amemiya A., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2020. PMID: 20301625.
9. Schefler A.C., Kim R.S. Recent advancements in the management of retinoblastoma and uveal melanoma. F1000Res 2018;7:F1000 Faculty Rev-476. doi: 10.12688/f1000research.11941.1.
10. Chantada G., Doz F., Antoneli C.B., Grundy R., Stannard F.F.C., Dunkel I.J., Grabowski E., Leal-Leal C., Rodriguez-Galindo C., Schvartzman E., Popovic M.B., Kremens B., Meadows A.T., Zucker J.M. A proposal for an international retinoblastoma staging system. Pediatr Blood Cancer 2006;47(6):801-5. doi: 10.1002/pbc.20606.
11. Kaewkhaw R., Rojanaporn D. Retinoblastoma: Etiology, Modeling, and Treatment. Cancers (Basel) 2020;12(8):2304. doi: 10.3390/cancers12082304.
12. Honavar S.G., Manjandavida F.P., Reddy V.A.P. Orbital retinoblastoma: an update. Indian J Ophthalmol 2017;65(6):435-42. doi: 10.4103/ijo.IJO_352_15.
13. Kaliki S., Tahiliani P., Mishra D.K., Srinivasan V., Ali M.H., Reddy V. Optic nerve infiltration by retinoblastoma. Predictive Clinical Features and Outcome. Retina 2016;36(6):1177-83. doi: 10.1097/IAE.0000000000000861.
14. AlAli A., Kletke S., Gallie B., Lam W.C. Retinoblastoma for Pediatric Ophthalmologists. Asia Pac J Ophthalmol (Phila) 2018;7(3):160-8. doi: 10.22608/APO.201870.
15. Chantada G., Schaiquevich P. Management of retinoblastoma in children: current status. Paediatr Drugs 2015;17(3):185-98. doi: 10.1007/s40272-015-0121-9.
16. Chantada G.L., Guitter M.R., Fandino A.C., Raslawski E.C., de Davila M.T., Vaiani E., Scopinaro M.J. Treatment results in patients with retinoblastoma and invasion to the cut end of the optic nerve. Pediatr Blood Cancer 2009;52(2):218-22. doi: 10.1002/pbc.21735.
17. Shannon C.E.G., Jaeger R., Forster F.M. The Combined Intracranial and Orbital Operation for Bilateral Retinoblastoma. Trans Am Ophthalmol Soc 1944;42:326-33. PMID: 16693356.
18. Sacks J.G., McLennan J.E. Transcranial enucleation for optic nerve tumor. Neurosurgery 1981;9(2):166-8. doi: 10.1227/00006123-198108000-00010.
19. Almarzouki H.S., Bababeygy S.R., Berry J.L., Murphree A.L. Optic nerve length in enucleated specimens of retinoblastoma eyes: a surgical approach to retinoblastoma. J AAPOS 2011;15(1):e11. doi: 10.1016/j.jaapos.2011.01.043.
20. Ushakova T.L., Volkova A.S., Gorbunova T.V., Gorovtsova O.V., Dolgopolov I.S., Mikhailova E.V., Panferova T.R., Glekov I.S., Polyakov V.G. Retinoblastoma with extraocular extension on the optic nerve: the case report. Rossiyskiy zhurnal detskoy gematologii i onkologii = Russian Journal of Pediatric Hematology and Oncology 2019;6(4):83-92. (In Russ.).
Review
For citations:
Ushakova T.L., Tuzova E.A., Shutova A.D., Gorovtsova O.V., Gasparyan T.G., Bekyashev A.Kh., Polyakov V.G. Extended surgical interventions in children with retinoblastoma invasion into the optic nerve. Russian Journal of Pediatric Hematology and Oncology. 2021;8(2):50-60. (In Russ.) https://doi.org/10.21682/2311-1267-2021-8-2-50-60